Dr. Danielle S. Cha
Dr. Danielle S. Cha
MD, University of Queensland School of Medicine
Verified email at uqconnect.edu.au
Title
Cited by
Cited by
Year
Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions
RS McIntyre, DS Cha, JK Soczynska, HO Woldeyohannes, LA Gallaugher, ...
Depression and anxiety 30 (6), 515-527, 2013
5752013
Inflamed moods: a review of the interactions between inflammation and mood disorders
JD Rosenblat, DS Cha, RB Mansur, RS McIntyre
Progress in Neuro-Psychopharmacology and Biological Psychiatry 53, 23-34, 2014
4702014
Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach
RS McIntyre, MJ Filteau, L Martin, S Patry, A Carvalho, DS Cha, M Barakat, ...
Journal of affective disorders 156, 1-7, 2014
2882014
The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project
RS McIntyre, JZ Soczynska, HO Woldeyohannes, MT Alsuwaidan, ...
Comprehensive psychiatry 56, 279-282, 2015
1212015
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
W Swardfager, N Herrmann, RS McIntyre, G Mazereeuw, K Goldberger, ...
Neuroscience & biobehavioral reviews 37 (5), 911-929, 2013
1172013
The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder
RS McIntyre, HX Xiao, K Syeda, M Vinberg, AF Carvalho, RB Mansur, ...
CNS drugs 29 (7), 577-589, 2015
822015
The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the …
RS McIntyre, JK Soczynska, DS Cha, HO Woldeyohannes, RS Dale, ...
Journal of affective disorders 172, 259-264, 2015
822015
Cannabidiol in medical marijuana: research vistas and potential opportunities
C Rong, Y Lee, NE Carmona, DS Cha, RM Ragguett, JD Rosenblat, ...
Pharmacological Research 121, 213-218, 2017
812017
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study
RB Mansur, J Ahmed, DS Cha, HO Woldeyohannes, M Subramaniapillai, ...
Journal of affective disorders 207, 114-120, 2017
782017
Predominant polarity as a course specifier for bipolar disorder: a systematic review
AF Carvalho, RS McIntyre, D Dimelis, X Gonda, M Berk, PR Nunes-Neto, ...
Journal of affective disorders 163, 56-64, 2014
702014
Treatment-emergent adverse events associated with atypical antipsychotics
DS Cha, RS McIntyre
Expert opinion on pharmacotherapy 13 (11), 1587-1598, 2012
682012
Gut emotions-mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders
A Slyepchenko, A F Carvalho, D S Cha, S Kasper, R S McIntyre
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
672014
The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project
RS McIntyre, JK Soczynska, SS Liauw, HO Woldeyohannes, E Brietzke, ...
The International Journal of Psychiatry in Medicine 43 (2), 165-177, 2012
642012
Advancing biomarker research: utilizing ‘Big Data’approaches for the characterization and prevention of bipolar disorder
RS McIntyre, DS Cha, JM Jerrell, W Swardfager, RD Kim, LG Costa, ...
Bipolar disorders 16 (5), 531-547, 2014
622014
Crosstalk between metabolic and neuropsychiatric disorders
O Kaidanovich-Beilin, DS Cha, RS McIntyre
F1000 biology reports 4, 2012
602012
The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder
RS McIntyre, MW Best, CR Bowie, NE Carmona, DS Cha, Y Lee, ...
The Journal of clinical psychiatry 78 (7), 873-881, 2017
592017
A new perspective on the anti-suicide effects with ketamine treatment: a procognitive effect
Y Lee, K Syeda, NA Maruschak, DS Cha, RB Mansur, IK Wium-Andersen, ...
Journal of clinical psychopharmacology 36 (1), 50-56, 2016
482016
A review of FDA-approved treatment options in bipolar depression
RS McIntyre, DS Cha, RD Kim, RB Mansur
CNS spectrums 18 (s1), 1-21, 2013
442013
Nitric oxide and major depressive disorder: pathophysiology and treatment implications
P Kudlow, DS Cha, AF Carvalho, RS McIntyre
Current molecular medicine 16 (2), 206-215, 2016
432016
Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder
PA Kudlow, DS Cha, RW Lam, RS McIntyre
Sleep medicine 14 (10), 943-949, 2013
412013
The system can't perform the operation now. Try again later.
Articles 1–20